Welcome to the e-CCO Library!

P664: The transitioning healthcare economy of IBD: changes in resource allocation over time
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Spizzo P.

Created: Wednesday, 20 February 2019, 10:36 AM
P665 Which second-line biologic after anti-TNF failure during Crohn’s disease: Ustekinumab or vedolizumab, a multicentre retrospective study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

C. Rayer1, X. Roblin2, D. Laharie3, B. Caron4, M. Flamant5, M. Dewitte1, M. Fumery6, S. Viennot7, A. Bourreille8, B. Pariente9, L. Siproudhis1, L. Peyrin-Biroulet10, G. Bouguen1

Created: Thursday, 30 January 2020, 10:12 AM
P665: 1-Year clinical and endoscopic follow-up of vedolizumab therapy in refractory PIBD patients
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. M. E. Jongsma*1, M. A. Aardoom1, L. de Ridder1, J. C. Escher1

Created: Friday, 22 February 2019, 9:41 AM
P665: Cardiovascular risk profile in chronic auto-inflammatory diseases: a cross-sectional single center study
Year: 2021
Source: ECCO'21 Virtual
Authors: Sleutjes, J.A.M.(1);Roeters van Lennep , J.E.(2);Verploegh , P.J.P.(1);van Doorn , M.B.A.(3);Vis , M.(4);van der Woude , C.J.(1);de Vries , A.C.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P665: Higher BMI but not systemic immune suppression increases the risk of short-term postoperative complications in Crohn’s disease patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Podmanicky1*, V. Bak1, M. Krizko2, Z. Zelinkova2

Created: Thursday, 21 February 2019, 9:14 AM
P665: Social Media Listening to better Understand the Lived Experience of Individuals With Ulcerative Colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Auriat, O.(1);Lucats, L.(1)*;Badalamenti, S.(2);Kruger, A.(2);Wiekowski, M.(2);Glotfelty, L.(2);Van Hoogstraten, H.(3);Coulouvrat, C.(4);
Created: Friday, 14 July 2023, 11:12 AM
P665: Towards FAIR longitudinal IBD registries: preliminary results of an iterative design process of a reusable and interoperable IBD database model
Year: 2022
Source: ECCO'22
Authors: Adriaans , G.M.C.(1,2);Hendrix , E.M.B.(1,2);Creemers , R.(2,3);Janssen , L.(1,2);Demers , K.(1,2);Rezazadeh Ardabili , A.(1,2);Jonkers , D.M.A.E.(1,2);Pierik , M.J.(1,2);
Created: Friday, 11 February 2022, 3:56 PM
P665: Unchanged infliximab serum concentrations after switching from the reference infliximab to the biosimilar CT-P13 in patients with quiescent Crohn's disease: a prospective study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Strik A.*1, van de Vrie W.2, van Megen Y.3, Bloemsaat-Minekus J.3, Rispens T.4, D'Haens G.1

Created: Wednesday, 20 February 2019, 10:36 AM
P666 Neutropenia in inflammatory bowel disease patients on TNF inhibitors: A single-centre, retrospective cohort study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

D. AlAskar, A. Mais, E. Al Sulais, T. Alameel

Created: Thursday, 30 January 2020, 10:12 AM
P666: Effect of anastomotic configuration on Crohn's Disease recurrence after primary ileocolic resection. A comparative monocentric study of end-to-end versus side-to-side anastomosis.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Bislenghi, G.(1);Vancoillie, P.J.(1)*;Fieuws, S.(2);Verstockt, B.(3);Sabino, J.(4);Wolthuis, A.(1);D'Hoore, A.(1);
Created: Friday, 14 July 2023, 11:12 AM
P666: Frequency and outcome of SARS-CoV2 infection in patients with inflammatory bowel disease on different biological therapy
Year: 2021
Source: ECCO'21 Virtual
Authors: Resál, T.(1);Farkas, K.(1);Molnár, T.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P666: Long-term effectiveness and safety of vedolizumab (VDZ) in inflammatory bowel disease (IBD): Results from the Spanish ENEIDA Registry
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Chaparro1,2,3,4*, A. Garre1,2,3,4, I. Alfaro4,5, M. Iborra4,6, P. Mesonero7, I. Vera Mendoza8, A. Rodríguez9, J. Miquel-Cusachs10, S. Riestra11, P. Navarro12, L. De Castro Parga13, C. González-Muñoza14, M. Rivero Tirado15, M. Mañosa4,16, L. Fernández Salazar17, M. García-Sepulcre18, J. Guardiola19, J. Cabriada20, A. Gutiérrez Casbas4,21, B. Sicilia22, J.L. Pérez Calle23, M. Piqueras24, I. Guerra25, O. Roncero26, M. Navarro-Llavat27, E. Sainz28, J. Barrio29, X. Calvet4,30, A. García31, M. Llorente Barrio32, R. Lorente33, P. Almela34, R. Madrigal35, A.J. Lucendo Villarín36, R. Pajares37, M. Van Domselaar38, J. Legido Gil39, J.P. Gisbert1,2,3,4

Created: Thursday, 21 February 2019, 9:14 AM
P666: Safety of combination biologic and immunosuppressive therapy post-orthotopic liver transplantation in patients with inflammatory bowel disease: a systematic review
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Al Draiweesh*1,2, C. Ma1,3, M. Alkhattabi1,4, T. Nguyen5, M. Brahmania1, V. Jairath1,6

Created: Friday, 22 February 2019, 9:41 AM
P666: Short-term outcomes of adalimumab for patients with Crohn's disease and associated prognostic factors: a multicentre retrospective cohort study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Nasuno M.*1, Tanaka H.1, Miyakawa M.1, Motoya S.1, Ishii M.2, Shiotani A.2, Yamashita M.3, Itoh F.3, Tanuma T.4, Sakemi R.5, So S.5, Suzuki R.6, Yanagisawa H.7, Onodera K.8, Kaneto H.9, Nojima M.10, Nakase H.8

Created: Wednesday, 20 February 2019, 10:36 AM
P666: Trend of Lower gastrointestinal Endoscopy in Patients with Inflammatory Bowel Diseases : A Nationwide Population-Based Study in South Korea
Year: 2022
Source: ECCO'22
Authors: Kim, S.(1);Lee, S.(2);Han, K.(2);Soh, H.(1);Koh, S.J.(3);Lee, H.J.(1);Im, J.P.(1);Kim, J.S.(1);
Created: Friday, 11 February 2022, 3:56 PM
P667 Combined therapy of perianal fistulas with autologous adipose-derived stem cells
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Surowiecka, M. Łodyga, M. Durlik, R. Grażyna

Created: Thursday, 30 January 2020, 10:12 AM
P667: Characterization of a large Hispanic cohort with Inflammatory Bowel Disease across a 25-year span
Year: 2021
Source: ECCO'21 Virtual
Authors: Torres, E.A.(1);Ramos, L.(1);Sanchez, A.(1);Amaya, C.(2);Perez-Gilbe, A.(3);
Created: Wednesday, 2 June 2021, 4:12 PM
P667: Safety of anti-TNF treatment in liver transplant recipients – a meta-analysis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Westerouen van Meeteren M.1, Inderson A.1, Hayee B.2, van der Meulen A.1, Altwegg R.3, van Hoek B.1, Pageaux G.-P.3, Stijnen T.4, Stein D.5, Maljaars J.*1

Created: Wednesday, 20 February 2019, 10:36 AM
P667: Standard vs. intensified infliximab rescue therapy for hospitalised paediatric patients with acute severe exacerbations of colitis-predominant inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

K.S. Singh1*, L. Hart2, A. Al Khoury1, C.-Y. Chao2,3, W. Afif2, P.L. Lakatos2, N. Ahmed4, T. Bessissow2

Created: Thursday, 21 February 2019, 9:14 AM
P667: Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates in 72 patients, a report from a district general hospital
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

P. Radhakrishnan*1, H. Johnson1, K. Wade1, S. McLaughlin1

Created: Friday, 22 February 2019, 9:41 AM